CSE: WBIO

Last: 0.04

Change: 0.00

Vol: 0

View Polish site

About Us
Portfolio
- Overview
- Brain Cancer
  - WPD101
  - Berubicin
  - WP1066
- Pancreatic Cancer
  - WP1066
- Melanoma
  - WPD102
- Other Cancers
  - WPD103
  - WP1220
  - Annamycin
Investors
News & Media
- Latest News
- Events
Procurement/RFP
For Patient
Contact Us

About Us
Portfolio
- Overview
- Brain Cancer
  - WPD101
  - Berubicin
  - WP1066
- Pancreatic Cancer
  - WP1066
- Melanoma
  - WPD102
- Other Cancers
  - WPD103
  - WP1220
  - Annamycin
Investors
News & Media
- Latest News
- Events
Procurement/RFP
For Patient
Contact Us

CSE: WBIO

Last: 0.04

Change: 0.00

Vol: 0

Financial Reports

Investors

Presentation
Stock Information
Share Structure
Financial Reports

Corporate Presentation
Download Fact Sheet
Download

Financials can be found on Company's SEDAR profile

Subscribe to our Newsletter

About Us
Portfolio
Investors
News & Media
- Latest News
- Events
Procurement/RFP
For Patient
Contact Us

Corporate Head Office

WPD Pharmaceuticals Sp. z o.o.
Żwirki i Wigury 101, 02-089 Warszawa, Poland
National Court Register, Distrtict Court for the capital city of Warszawa in Warszawa, Poland
XII Commercial Division of the National Court Register
KRS: 0000693186, TAX Identification No.: 5252721500
Initial capital of PLN 2 969 200
Telephone No.: +48 515 262 381

Canada Corporate Office

Vancouver Office
Suite 1080, 789 West Pender Street
Vancouver, BC
V6C 1H2

Careers Privacy Policy Legal Note Cookies Policy © 2023 WPD Pharmaceuticals. All Rights Reserved

Designed and Powered by BLENDER